Literature DB >> 22993021

A new case with 10q23 interstitial deletion encompassing both PTEN and BMPR1A narrows the genetic region deleted in juvenile polyposis syndrome.

Marija Hiljadnikova Bajro1, Elena Sukarova-Angelovska, Jose Adélaïde, Max Chaffanet, Aleksandar J Dimovski.   

Abstract

We report on a patient with a contiguous interstitial germline deletion of chromosome 10q23, encompassing BMPR1A and PTEN, with clinical manifestations of juvenile polyposis and minor symptoms of Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS). The patient presented dysmorphic features as well as developmental delay at the age of 5 months. Multiple polyps along all parts of the colon were diagnosed at the age of 3 years, following an episode of a severe abdominal pain and intestinal bleeding. The high-resolution comparative genomic hybridisation revealed a 3.7-Mb deletion within the 10q23 chromosomal region: 86,329,859-90,035,024. The genotyping with four polymorphic microsatellite markers confirmed a de novo 10q deletion on the allele with a paternal origin, encompassing both PTEN and BMPR1A genes. The karyotype analysis additionally identified a balanced translocation involving chromosomes 5q and 7q, and an inversion at chromosome 2, i.e. 46,XY,t(5;7)(q13.3-q36), inv(2)(p25q34). Although many genetic defects were detected, it is most likely that the 10q23 deletion is primarily the cause for the serious phenotypic manifestations. The current clinical findings and deletion of BMPR1A indicate a diagnosis of severe juvenile polyposis, but the existing macrocephaly and PTEN deletion also point to either CS or BRRS, which cannot be ruled out at the moment because of their clinical manifestation later in life and the de novo character of the deletion. The deletion detected in our patient narrows the genetic region deleted in all reported cases with juvenile polyposis by 0.04 Mb from the telomeric side, mapping it to the region chr10:88.5-90.03Mb (GRCh37/hg19), with an overall length of 1.53 Mb.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993021     DOI: 10.1007/s13353-012-0115-z

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  16 in total

Review 1.  Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23.

Authors:  F S Dahdaleh; J C Carr; D Calva; J R Howe
Journal:  Clin Genet       Date:  2011-09-06       Impact factor: 4.438

2.  Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy.

Authors:  Leonardo Salviati; Mariagrazia Patricelli; Graziella Guariso; Giacomo Carlo Sturniolo; Rita Alaggio; Franca Bernardi; Orsetta Zuffardi; Romano Tenconi
Journal:  Am J Hum Genet       Date:  2006-09       Impact factor: 11.025

3.  Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes.

Authors:  Capucine Delnatte; Damien Sanlaville; Jean-Francois Mougenot; Joris-Robert Vermeesch; Claude Houdayer; Marie-Christine de Blois; David Genevieve; Olivier Goulet; Jean-Pierre Fryns; Francis Jaubert; Michel Vekemans; Stanislas Lyonnet; Serge Romana; Charis Eng; Dominique Stoppa-Lyonnet
Journal:  Am J Hum Genet       Date:  2006-04-14       Impact factor: 11.025

4.  Del(10)(q22.3q24.1) associated with juvenile polyposis.

Authors:  R F Jacoby; S Schlack; G Sekhon; R Laxova
Journal:  Am J Med Genet       Date:  1997-06-27

5.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.

Authors:  D J Marsh; J B Kum; K L Lunetta; M J Bennett; R J Gorlin; S F Ahmed; J Bodurtha; C Crowe; M A Curtis; M Dasouki; T Dunn; H Feit; M T Geraghty; J M Graham; S V Hodgson; A Hunter; B R Korf; D Manchester; S Miesfeldt; V A Murday; K L Nathanson; M Parisi; B Pober; C Romano; C Eng
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

7.  Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome.

Authors:  K D Tsuchiya; G Wiesner; S B Cassidy; C Limwongse; J T Boyle; S Schwartz
Journal:  Genes Chromosomes Cancer       Date:  1998-02       Impact factor: 5.006

8.  Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.

Authors:  E M Arch; B K Goodman; R A Van Wesep; D Liaw; K Clarke; R Parsons; V A McKusick; M T Geraghty
Journal:  Am J Med Genet       Date:  1997-09-05

9.  High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome.

Authors:  S Aretz; D Stienen; S Uhlhaas; M Stolte; M M Entius; S Loff; W Back; A Kaufmann; K-M Keller; S H Blaas; R Siebert; S Vogt; S Spranger; E Holinski-Feder; L Sunde; P Propping; W Friedl
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

10.  Contribution of PTEN large rearrangements in Cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach.

Authors:  F Chibon; C Primois; J-M Bressieux; D Lacombe; C Lok; L Mauriac; A Taieb; M Longy
Journal:  J Med Genet       Date:  2008-05-02       Impact factor: 6.318

View more
  2 in total

1.  Gastrointestinal Polyposis in Pediatric Patients.

Authors:  Suzanne P MacFarland; Kristin Zelley; Bryson W Katona; Benjamin J Wilkins; Garrett M Brodeur; Petar Mamula
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

2.  Aggressive juvenile polyposis in children with chromosome 10q23 deletion.

Authors:  Seth Septer; Lei Zhang; Caitlin E Lawson; Jose Cocjin; Thomas Attard; Holly H Ardinger
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.